1-(3-Bromo-4-(1H-pyrazol-1-yl)phenyl)ethanone, 95.0%, 25g

(2S,3S)-3-(tert-Butyl)-2-isopropyl-4-(2-methoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole, 95.00%, 100mg

8-Bromocinnoline, 95+%, 1g

1,2,3,5,6,7-Hexahydro-s-indacen-4-amine, 98.0%, 5g

(3R,4R)-tert-Butyl 4-(aminomethyl)-3-hydroxypiperidine-1-carboxylate, 95.0%, 1g

(5-Bromothien-2-yl)methanol, 95.0%, 5g

2-(2,5-Dimethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 10g

5-Aminobenzimidazole, 97.0%, 100g

(4R,4'R)-2,2'-(Cyclohexane-1,1-diyl)bis(4-phenyl-4,5-dihydrooxazole), 97% 99%ee, 250mg

5-oxo-5-phenylvaleric acid, 97.0%, 100g

Vinylmethylsiloxane-dimethylsiloxane copolymer silanol terminated cSt 25-40, 100g

1-(3-BROMOPHENYL)PIPERAZIN-2-ONE HCL, 95.0%, 1g

Sodium DL-Mandelate>99.0%(HPLC)(T)25g